Skip to content

Semi-automated Quantitative Ventilation-Perfusion SPECT/CT Multiparametric Analysis for Prognostic Evaluation and Treatment Response Assessment in Acute and Chronic Thromboembolic Pulmonary Disease

Semi-automated Quantitative Ventilation-Perfusion SPECT/CT Multiparametric Analysis for Prognostic Evaluation and Treatment Response Assessment in Acute and Chronic Thromboembolic Pulmonary Disease: A Single-Center, Prospective, Observational Cohort Study Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129666
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pulmonary embolism

Interventions

Acute pulmonary embolism cohort:No
Chronic thromboembolic pulmonary disease cohort:No

Sponsors

Zhongshan Hospital Affiliated to Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age =18 years; 2.For the acute pulmonary embolism cohort: patients with acute symptomatic pulmonary embolism confirmed by computed tomography pulmonary angiography or ventilation/perfusion imaging; 3.For the chronic thromboembolic pulmonary disease cohort: patients fulfilling the diagnostic criteria for chronic thromboembolic pulmonary disease, with or without pulmonary hypertension; 4.Eligible for ventilation/perfusion SPECT/CT imaging; 5.Ability to understand the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications for SPECT/CT examination; 2. Image quality insufficient for quantitative analysis; 3. Severe lung diseases, pulmonary bullae, infections, pleural effusion, lung tumors, etc.; 4. History of lung surgery; 5. Pregnancy or breastfeeding; 6. Expected lifespan < 12 months; 7. Severe chronic obstructive pulmonary disease.

Design outcomes

Primary

MeasureTime frame
Time to the first occurrence of a composite clinical worsening event;

Secondary

MeasureTime frame
Change in WHO functional class;Change in BNP or NT-proBNP levels;Semi-automated quantitative V/Q SPECT/CT parameters;Change in six-minute walk distance;

Countries

China

Contacts

Public ContactZhang Hong

Zhongshan Hospital Affiliated to Xiamen University

68138867@qq.com+86 592 299 3352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026